-52.5%
OPEN vs GSK
+64.4%
-117.0%
-89.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.0% | -0.1% | -5.0% | -5.0% |
| 7D | -19.9% | -1.3% | -18.5% | -19.6% |
| 30D | -46.6% | +2.7% | -49.3% | -46.9% |
| 3M | -69.0% | +2.7% | -71.7% | -69.1% |
| 6M | -74.2% | +3.3% | -77.5% | -74.5% |
| YTD | -80.6% | +6.5% | -87.1% | -81.6% |
| 1Y | -86.1% | +10.7% | -96.7% | -87.0% |
| 3Y | -52.5% | +64.4% | -116.9% | -71.8% |
| All | -52.5% | +64.4% | -117.0% | -71.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling